Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 41 - 60 out of 500 displayed.
«  1  2 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

ORYZON Reports Financial Results and Corporate Update for the 4th Quarter and Year Ended December 31, 2018

Read more ››
By: Nasdaq / GlobenewsWire - 15 Feb 2019
Related companies:  Oryzon Genomics, S.A.

HEXO Corp. enters into $65 million bank debt facility

Read more ››
By: Nasdaq / GlobenewsWire - 15 Feb 2019

Sienna Announces February Dividend

Read more ››
By: Nasdaq / GlobenewsWire - 15 Feb 2019

Kiadis Pharma Notice of Extraordinary General Meeting of Shareholders

Read more ››
By: Nasdaq / GlobenewsWire - 15 Feb 2019
Related companies:  Kiadis Pharma N.V.

CBS News Interviews Dr. Ashraf Hanna and Patient About Ketamine Treatments for Patients at High Suicide Risk and Depression

CLEARWATER, Fla., Feb. 15, 2019 /PRNewswire/ -- From 1999 to 2016, the rate of suicides in the U.S. increased by 30 percent. It's now the second-leading cause of death for 10 to 34-year-olds. Social media bullying, increasing economic disparity, returning veterans traumatized by war, and unintended... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2019

Avapritinib receives Phase III clinical trial approval for GIST in China

SUZHOU, China, Feb. 15, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone") today announced that the National Medical Products Administration (NMPA) recently approved a Phase III clinical trial in China for its partnered drug candidate avapritinib as a third-line treatment against KIT-driven... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2019
Related companies:  CStone Pharmaceuticals

Medical leaders back clinical utility of sphingotec's blood biomarker bio-ADM®

HENNIGSDORF, Germany, Feb. 15, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 15 Feb 2019
Related companies:  sphingotec GmbH

Launch of BMJ Author Services in Collaboration with Editage

LONDON, Feb. 15, 2019 /PRNewswire/ -- Healthcare knowledge provider BMJ has partnered with Editage to offer language editing and translation services to medical researchers who seek to publish in healthcare science journals.

Read more ››
By: PR Newswire Association LLC. - 15 Feb 2019

Nevro Files Lawsuit for Patent Infringement Against Stimwave in the U.S.

REDWOOD CITY, Calif., Feb. 15, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that it has filed a lawsuit for patent infringement against Stimwave Technologies,... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2019
Related companies:  Nevro Corp.

Hoth Therapeutics Inc. Announces Pricing of Initial Public Offering and Trading on the Nasdaq Capital Market Under the Ticker Symbol "HOTH"

NEW YORK, Feb. 15, 2019 /PRNewswire/ -- Hoth Therapeutics Inc. ("Hoth" or the "Company"), a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema, today announced the pricing... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2019
Related companies:  Hoth Therapeutics Inc.

VSY Biotechnology BV and Carl Zeiss Meditec AG Settled Their Legal Disputes

AMSTERDAM, Feb. 15, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 15 Feb 2019

Near Infrared Imaging Market Worth $822 Million by 2023 - Exclusive Report by MarketsandMarkets™

CHICAGO, Feb. 15, 2019 /PRNewswire/ -- According to the new market research report "Near Infrared Imaging Market by Product Type (NIR Fluorescence Imaging, Reagents), Application (Cancer surgery, Plastic surgery, Gastrointestinal surgery) End Users (Hospitals & Clinics, Research laboratory,... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2019

BioCorRx Inc. to Webcast Live at VirtualInvestorConferences.com February 20th

ANAHEIM, Calif., Feb. 15, 2019 /PRNewswire/ -- BioCorRx Inc. (BICX), based in Anaheim, CA, Leader in addiction treatment solutions and drug development implementation, today announced that Brady Granier, CEO/President and Lourdes Felix, CFO/COO, will present live at VirtualInvestorConferences.com... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2019
Related companies:  BIOCORRX, INC.

Colorado Mesothelioma Victims Center Now Urges a Navy Veteran with Mesothelioma or Lung Cancer Anywhere in Colorado to Call Them for Direct Access to Attorney Erik Karst A Leading National Expert on Compensation Claims

DENVER, Feb. 15, 2019 /PRNewswire/ -- The Colorado Mesothelioma Victims Center is appealing... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2019

FRX Health Announces Grand Opening

EAST LIVERPOOL, Ohio, Feb. 15, 2019 /PRNewswire/ -- FRX Health(TM) is excited to announce the opening of its Ohio Dispensary on February 7(th), 2019. FRX Health was awarded a license by Ohio's Medical Marijuana Control Program last summer. The Dispensary is located at 1865 Dresden Avenue in East... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2019

Patient Groups Provide Educational Cannabis Content to Arizona Voters

PHOENIX, Feb. 15, 2019 /PRNewswire/ -- The American Council for Patient Liberty created a website and produced an educational video to inform Arizonans and elected officials about voter protected medical marijuana as well as hemp extracts in Arizona. House Bill 2149 sponsored by Representative... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2019

Lilly Completes Acquisition of Loxo Oncology

INDIANAPOLIS, Feb. 15, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced the successful completion of its acquisition of Loxo Oncology, Inc. (NASDAQ:LOXO). The acquisition broadens the scope of Lilly's oncology portfolio into precision medicines through the addition of a pipeline... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2019
Related companies:  Loxo Oncology, Inc. | Eli Lilly and Company

Bayer to obtain full rights to global development and commercialization of oncology compounds Vitrakvi® (larotrectinib) and BAY 2731954 (LOXO-195)

WHIPPANY, N.J., Feb. 15, 2019 /PRNewswire/ -- Bayer has exercised its option, under a change-in-control clause in the collaboration agreement with Loxo Oncology, to obtain the exclusive licensing rights for the global development and commercialization, for Vitrakvi® (larotrectinib) and BAY 2731954... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2019
Related companies:  Bayer HealthCare, LLC Animal Health Division | Bayer CropScience LP | Loxo Oncology, Inc. | Bayer Healthcare LLC

Statement from FDA Commissioner Scott Gottlieb, M.D., on new policy to improve access and foster price competition for drugs that face inadequate generic competition

SILVER SPRING, Md., Feb. 15, 2019 /PRNewswire/ -- In too many cases, branded drugs that are no longer protected by patents or other exclusivities do not face expected competition. In fact, there are several hundred of such branded drugs that do not have any generic competition. Instances... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2019
Related companies:  U.S. Food and Drug Administration

FDA advances new efforts to promote development of safe and effective regenerative medicine products

SILVER SPRING, Md., Feb. 15, 2019 /PRNewswire/ -- "We're at an inflection point when it comes to cell and gene therapies. These treatments have the potential to address hundreds of vexing human diseases and conditions. When we first issued our comprehensive regenerative medicine policy framework... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2019
Related companies:  U.S. Food and Drug Administration
«  1  2 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑